Public urged to sign up to world-first COVID-19 antiviral study

The UK government is encouraging adults over the age of 50 or with an underlying health condition who test positive for Covid-19 to sign up for a world-first study which is providing life-saving antivirals to thousands of people.

The study is run by the University of Oxford and supported by the National Institute for Health Research (NIHR) with a recruitment drive backed by charities including Kidney Care UK, Cystic Fibrosis Trust, Diabetes UK and the British Liver Trust as antivirals help protect most vulnerable from hospital.

At least 6,000 more participants needed as soon as possible so the life-saving treatments can be rolled out more widely.

Participants can sign up at the PANORAMIC trial website.